Antioxidant tested to shield patients from Chemo's painful side effect
NCT ID NCT07391163
Summary
This study tested whether a common antioxidant supplement, N-Acetylcysteine (NAC), could protect against nerve damage (peripheral neuropathy) caused by a standard colon cancer chemotherapy drug, oxaliplatin. Forty-six adult patients with colorectal cancer were randomly assigned to receive either NAC alongside their chemotherapy or chemotherapy alone. Researchers measured the severity of nerve pain, numbness, and tingling to see if NAC made a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta University - Faculty of Medicine ,oncology department, Tanta university hospital.
Tanta, Egypt
Conditions
Explore the condition pages connected to this study.